Role of Metabolites in Nicotine Dependence (2) - 5
NCT00000288 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2017-01-12
Summary
The purpose of this study is to determine the effects of varying doses of cotinine on cigarette self-administration.
Conditions
- Tobacco Use Disorder
Interventions
- DRUG
-
Cotinine fumarate
Sponsors & Collaborators
- collaborator OTHER
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Dorothy Hatsukami, Ph.D. · University of Minnesota
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1995-12-31
- Completion
- 2002-12-31
Countries
- United States
Study Locations
More Related Trials
-
Palatability of Experimental Cigarettes - Study 2
NCT01568905 ·Status: COMPLETED ·Phase: NA
-
Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2
NCT00136838 ·Status: COMPLETED ·Phase: NA
-
The Role of Nicotine and Non-Nicotine Alkaloids in E-Cigarette Use and Dependence
NCT02590393 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Nicotinic Hepatic Metabolism on Neuroreceptor Substrates of Nicotine Addiction
NCT03442413 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
NCT00967005 ·Status: COMPLETED ·Phase: PHASE2
-
Manipulating Tobacco Constituents in Female Menthol Smokers
NCT02048852 ·Status: COMPLETED ·Phase: NA
-
Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol
NCT03580525 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Nicotine Pharmacokinetics and Smoking Behaviour Study Examining Cigarette Ingredients
NCT03272295 ·Status: COMPLETED ·Phase: NA
-
Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use
NCT02870218 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1
NCT00158171 ·Status: COMPLETED ·Phase: PHASE2
-
Varenicline For Smokers In Recovery From Alcohol Dependence
NCT01092702 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Metabolism-informed Care for Smoking Cessation
NCT03227679 ·Status: COMPLETED ·Phase: NA
-
The Effects of Menthol as Delivered by an Electronic Cigarette on the Desirability of Nicotine in Tobacco Users
NCT02102100 ·Status: COMPLETED ·Phase: NA
-
Effect of Orexin System on Nicotine Addiction and Its Neural Mechanism
NCT05947162 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of Smoking Abstinence
NCT01035632 ·Status: COMPLETED
-
Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal Nicotine
NCT00777569 ·Status: COMPLETED ·Phase: PHASE2
-
Human Laboratory Study Of Varenicline in Smokers
NCT00709696 ·Status: COMPLETED ·Phase: NA
-
CSD170304: Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes
NCT03294356 ·Status: COMPLETED ·Phase: NA
-
Association of Functional COMT Val108/Met Polymorphism With Smoking Cessation in Nicotine Replacement Therapy
NCT01980550 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment for Nicotine Addiction in Women
NCT02448654 ·Status: COMPLETED ·Phase: NA
-
Nicotine Metabolizers and [11C]-(+)-PHNO
NCT02514720 ·Status: COMPLETED ·Phase: NA
-
Nicotinic Receptor Levels After Stopping Smoking
NCT01704573 ·Status: COMPLETED
-
Nicotine's Potential Abuse With Menthol
NCT04535362 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Single-dose Pharmacokinetics of Oral Nicotine Replacement Products
NCT01228617 ·Status: COMPLETED ·Phase: NA
-
The Effects of Sedatives on Tobacco Use Disorder Version 2
NCT05505630 ·Status: COMPLETED ·Phase: EARLY_PHASE1